[PDF][PDF] Immunity to enteric viruses
Pathogenic enteric viruses are a major cause of morbidity and mortality, particularly among
children in developing countries. The host response to enteric viruses occurs primarily within …
children in developing countries. The host response to enteric viruses occurs primarily within …
[HTML][HTML] Mucosal immunity to poliovirus
RI Connor, EB Brickley, WF Wieland-Alter… - Mucosal …, 2022 - Elsevier
A cornerstone of the global initiative to eradicate polio is the widespread use of live and
inactivated poliovirus vaccines in extensive public health campaigns designed to prevent …
inactivated poliovirus vaccines in extensive public health campaigns designed to prevent …
Longitudinal systemic and mucosal immune responses to SARS-CoV-2 infection
PF Wright, AC Prevost-Reilly… - The Journal of …, 2022 - academic.oup.com
Background A longitudinal study was performed to determine the breadth, kinetics, and
correlations of systemic and mucosal antibody responses to severe acute respiratory …
correlations of systemic and mucosal antibody responses to severe acute respiratory …
[HTML][HTML] Intradermal fractional-dose inactivated polio vaccine (fIPV) adjuvanted with double mutant Enterotoxigenic Escherichia coli heat labile toxin (dmLT) is well …
JW Crothers, ER Colgate, KJ Cowan, DM Dickson… - Vaccine, 2022 - Elsevier
Eradication of poliomyelitis globally is constrained by fecal shedding of live polioviruses,
both wild-type and vaccine-derived strains, into the environment. Although inactivated polio …
both wild-type and vaccine-derived strains, into the environment. Although inactivated polio …
Fecal shedding of 2 novel live attenuated oral poliovirus type 2 vaccine candidates by healthy infants administered bivalent oral poliovirus vaccine/inactivated …
C Gast, AS Bandyopadhyay… - The Journal of …, 2022 - academic.oup.com
Background Primary intestinal immunity through viral replication of live oral vaccine is key to
interrupt poliovirus transmission. We assessed viral fecal shedding from infants …
interrupt poliovirus transmission. We assessed viral fecal shedding from infants …
Quantitative RT-PCR assays for quantification of undesirable mutants in the novel type 2 oral poliovirus vaccine
H Manukyan, R Wahid, A Ansari, E Tritama… - Vaccines, 2022 - mdpi.com
Emergence of mutations is an inherent property of RNA viruses with several implications for
their replication, pathogenesis, and evolutionary adaptation. Oral poliovirus vaccine (OPV) …
their replication, pathogenesis, and evolutionary adaptation. Oral poliovirus vaccine (OPV) …
Intestinal antibody responses to 2 novel live attenuated type 2 oral poliovirus vaccines in healthy adults in Belgium
EB Brickley, RI Connor, W Wieland-Alter… - The Journal of …, 2022 - academic.oup.com
In a blinded phase 1 trial (EudraCT 2017-0000908-21; NCT03430349) in Belgium, healthy
adults (aged 18–50 years) previously immunized exclusively with inactivated poliovirus …
adults (aged 18–50 years) previously immunized exclusively with inactivated poliovirus …
Is Measurement of Systemic IgG Antibodies the Wrong Way to Assess COVID-19 Vaccine Effectiveness for Breakthrough Infections?
SS Levinson - The Journal of Applied Laboratory Medicine, 2022 - academic.oup.com
Although vaccination against SARS-CoV-2 has substantially reduced severe disease, there
have been many milder breakthrough infections. One possible explanation for these …
have been many milder breakthrough infections. One possible explanation for these …
Immunogenicity and Safety of the Booster Dose of Polio Immunisation by Sabin Inactivated or Bivalent Oral Poliovirus Vaccine in Children Aged 4 Years with Different …
X Tang, Y Xiao, X Deng, Y Zhou, H Chen, R Yan, Y Zhu… - papers.ssrn.com
Background: Sabin inactivated and bivalent oral poliovirus vaccine (sIPV, bOPV) were
commonly used in China since 2016. We conducted a continuous open-label, randomised …
commonly used in China since 2016. We conducted a continuous open-label, randomised …